(Q44632359)

4 December 2017

title

Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells (English)

1 reference

4 December 2017

1 reference

12

June CH

1 reference

4 December 2017

2

Levine BL

1 reference

4 December 2017

A. P. Rapoport

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

A. Badros

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

B. Meisenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

K. Ruehle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

A. Nandi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

S. Rollins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

S. Natt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

B. Ratterree

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

S. Westphal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

D. Mann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578928

25 March 2024

language of work or name

English

0 references

publication date

1 January 2004

1 reference

full work available at URL

4 December 2017

https://www.nature.com/articles/1704317

1 reference

DOI

10.1038/SJ.BMT.1704317

https://api.crossref.org/works/10.1038/SJ.BMT.1704317

https://www.nature.com/articles/1704317.pdf

25 March 2024

file format

Portable Document Format

1 reference

DOI

10.1038/SJ.BMT.1704317

https://api.crossref.org/works/10.1038/SJ.BMT.1704317

Bone Marrow Transplantation

25 March 2024

published in

1 reference

4 December 2017

volume

33

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

53-60

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704317

4 December 2017

exact match

0 references

cites work

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Cytokine enhancement of immunogenicity in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

Marrow transplantation for the treatment of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704317

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704317

1 reference

Dimensions Publication ID

4 December 2017

1004709499

0 references

1 reference